States get a six-month cushion on Medicaid work rules

The Trump administration has delayed enforcement of new Medicaid work requirements until July, giving states extra time as they prepare new eligibility checks that could affect coverage continuity.
What Democrats’ Drug-Price Probe Could Mean for Patients

House Democrats are preparing to scrutinize drug pricing as Congress returns to Washington, reviving a long-running debate over what patients pay and why.
Congress’s new health committee lineup could reshape oversight

Democratic control of Congress is set to alter the committees that steer Medicare, drug pricing and broader health policy, while adding lawmakers with medical and scientific backgrounds.
Democrats Put Health Coverage Costs at the Top of Their New Agenda

House Democrats are signaling an early push on Medicaid and Affordable Care Act subsidies, a move that could affect coverage and out-of-pocket costs for millions of Americans.
Medicare’s Remote Monitoring Delay Gives Opponents Time to Organize

Medicare has delayed a major remote patient monitoring overhaul until 2029, setting up a longer fight over how home-based tracking services are delivered, staffed, and paid for.
Judge Blocks Stricter Medicaid Frailty Test in Work Rule Case

A federal judge stopped the Trump administration from enforcing a narrower standard for Medicaid’s medically frail exemptions, a move that could help some people keep coverage as new work rules approach.
Federal nursing-home job aid targets a long-running staffing gap

A new federal workforce effort would use loan repayment and stipends to encourage nurses to take nursing-home jobs in underserved areas, but experts say staffing problems are broader than one program can solve.
When Cancer Drugs Run Short, Patients Feel the Gap

A Washington Post report describes how some U.S. cancer patients and clinicians are turning to overseas sources when key medicines run short. The broader pattern reflects a stubborn reality: shortages can delay treatment, force substitutions, and create new safety questions.
Trump order targets women’s health research, with menopause and aging in focus

A new White House order aims to expand federal attention to women’s health research. Here’s what it could mean, what science already shows, and what remains unclear.
Medicare open enrollment starts with bigger drug-cost changes ahead

Medicare’s open enrollment season is under way, and several policy changes scheduled for 2027 could affect drug costs, plan choices and access to widely used diabetes and weight-loss medicines.